Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich entity will be the first to announce coverage for BlueBird Bio's gene therapy for sickle cell disease?
UnitedHealthcare • 25%
Anthem • 25%
Aetna • 25%
Cigna • 25%
Official announcements or press releases from the entities
12-Year-Old Kendric Cromer Receives $2.2 Million Gene Therapy for Sickle Cell Disease
Sep 16, 2024, 11:50 PM
Kendric Cromer, a 12-year-old boy, has become one of the first children to be treated with a newly approved gene therapy for sickle cell disease. This treatment, developed by BlueBird Bio, offers hope for a cure and a future free from the excruciating pain that has characterized his life. However, the high cost of the treatment, priced at $2.2 million, poses significant challenges. Insurers are hesitant to cover the expense, and hospitals are wary of the financial burden. The approval of this gene therapy by the FDA marks a significant milestone, but accessibility remains a critical issue for many patients. Deepak Srivastava highlights the broader issue of how to pay for breakthrough cures.
View original story
New England Journal of Medicine • 25%
Journal of the American Medical Association • 25%
The Lancet • 25%
Other • 25%
Safety warning update • 25%
Clinical trial halt • 25%
No action • 25%
Other action • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Novartis • 25%
Roche • 25%
Other • 25%
Editas Medicine • 25%
Intellia Therapeutics • 25%
CRISPR Therapeutics • 25%
Other • 25%
Adaptimmune (Afami-cel) • 25%
Checkpoint Therapeutics (Cosibelimab) • 25%
Mirati Therapeutics (Adagrasib-Cetuximab) • 25%
Other • 25%
Universal gene therapy • 33%
Mutation-specific gene therapy • 33%
No approval • 34%
Yes • 50%
No • 50%
CRISPR Therapeutics • 25%
Intellia Therapeutics • 25%
Beam Therapeutics • 25%
Other • 25%
Improved survival rates • 25%
Increased cancer rates • 25%
Stable condition • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Less than $500,000 • 25%
More than $1,500,000 • 25%
$1,000,000 - $1,500,000 • 25%
$500,000 - $1,000,000 • 25%